Byetta
exenatide
- Strength
- 250 ug/mL
- Form
- Injection
- Class
- GLP-1 Receptor Agonist
AstraZeneca Pharmaceuticals LP
Not stocked by us — reference only
Listed by Amneal Pharmaceuticals LLC
| Dosage form | Injection |
|---|---|
| Route | Subcutaneous |
| Drug class | GLP-1 Receptor Agonist |
| Approval route | ANDA — approved generic |
| NDC code | 70121-1686 |
| FDA application | ANDA206697 |
| RxNorm concept | 847910 |
| Package sizes listed | 1 |
| Marketed since | November 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
exenatide
AstraZeneca Pharmaceuticals LP
Not stocked by us — reference only
exenatide
AstraZeneca Pharmaceuticals LP
Not stocked by us — reference only
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.